CoChat

Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell Proliferation

Open access
Nakahara, Makiko, Okumura, Naoki, Nakano, Shinichiro, Koizumi, Noriko · 2018 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Purpose: We have performed clinical research on cell-based therapy for corneal endothelial decompensation since 2013. The purpose of this study was to investigate the usefulness of a p38 MAPK inhibitor for promoting proliferation of human corneal endothelial cells (HCECs). Methods: HCECs were cultured in media supplemented with various low-molecular-weight compounds to screen for the effect of those compounds on cell proliferation. Activation of substrates of p38 MAPK and cell cycle regulatory proteins were evaluated by western blotting. Corneal endothelial wounds were created in a rabbit model, and p38 MAPK was applied in eye drop form, followed by evaluation of cell proliferation in the corneal endothelium by Ki67-immunostaining. Results: HCECs cultured with SB203580 exhibited hexagonal morphology and similar size and morphology, whereas control HCECs cultured without inhibitor exhibited monolayer morphology and varied in size and morphology. Flow cytometry demonstrated that cell proliferation was significantly increased by SB203580. Western blotting showed activation of ATF2 and HSP27 (substrates of p38 MAPK), and upregulation of cyclin D and downregulation of p27 were induced by inhibiting p38 MAPK. In the rabbit model, promotion of wound healing of the corneal endothelium was associated with significant upregulation of Ki67-positive proliferating cells following topical administration of SB203580 when compared with untreated endothelium (50.9% and 36.1%, respectively). Conclusions: Activation of p38 MAPK signaling due to culture stress might suppress the proliferation of HCECs, whereas a p38 MAPK inhibitor can counteract this activation and enable efficient in vitro HCEC expansion.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.18-24394

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 34

Metadata

Authors
Nakahara, M., Okumura, N., Nakano, S., & Koizumi, N.
Affiliations
Doshisha University (JP)
Corresponding author
Koizumi, Noriko
Venue
Investigative Opthalmology & Visual Science
Published
2018-08-20
Volume
59
Issue
10
Pages
4218
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2888611927
Cited by
30
References
52
Citations by year
2025: 6 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 3
FWCI
2.41
Type
journal article
Language
en
Open access
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science (18K09464)
Topics
  • Health Sciences › Medicine › Ophthalmology › Corneal Surgery and Treatments
  • Health Sciences › Medicine › Ophthalmology › Corneal surgery and disorders
  • Health Sciences › Medicine › Ophthalmology › Ocular Surface and Contact Lens
Keywords
p38 MAPK inhibitor, SB203580, corneal endothelial cells, cell proliferation, corneal endothelial decompensation, cell therapy, ATF2, HSP27, cyclin D, p27, Ki-67, eye drops, rabbit model
MeSH terms
Animals, Cells, Cultured, Disease Models, Animal, Endothelium, Corneal, Humans, Imidazoles, Pyridines, Rabbits, Blotting, Western, Endothelial Cells, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, Cell Proliferation, Cell- and Tissue-Based Therapy, Corneal Injuries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.